Immunocore Holdings reported a gross margin of 99.06% and a net margin of -0.70% for the quarter ended Jun 2026. These financial ratios cover 21 quarters of results from Dec 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2019 | Dec2020 | Sep2021 | Dec2021 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||
| Gross Margin | 100.00% | 100.00% | 99.23% | 99.85% | 99.77% | 99.60% | 98.17% | 99.57% | 99.71% | 99.65% | 97.74% | 99.44% | 99.61% | 99.11% | 98.94% | 99.51% | 97.41% | 99.59% | 99.06% | ||
| EBT Margin | -544.55% | -594.19% | -55.57% | 12.10% | -48.01% | -35.05% | -28.15% | 1.13% | -36.55% | -34.15% | -13.44% | 7.59% | -29.53% | 6.48% | -9.90% | 0.29% | -15.12% | 12.44% | -0.44% | ||
| EBIT Margin | -522.45% | -573.82% | -51.43% | 14.98% | -46.45% | -26.89% | -33.03% | -21.81% | -24.30% | -37.57% | -21.24% | -10.59% | -23.14% | -3.85% | -15.18% | -6.92% | -18.85% | 6.82% | -2.58% | ||
| EBITDA Margin | -522.45% | -573.82% | -51.43% | 14.98% | -46.45% | -26.89% | -33.03% | -21.81% | -24.30% | -37.57% | -21.24% | -10.59% | -23.14% | -3.85% | -15.18% | -6.92% | -18.85% | 6.82% | -2.58% | ||
| Operating Margin | -522.45% | -573.82% | -51.43% | 14.98% | -46.45% | -26.89% | -23.02% | -21.81% | -24.30% | -37.57% | -21.24% | -10.59% | -23.14% | -3.85% | -15.18% | -6.92% | -18.85% | 6.82% | -2.58% | ||
| Net Margin | -508.68% | -597.44% | -48.85% | 15.12% | -52.44% | -35.60% | -29.48% | 1.40% | -28.12% | -34.72% | -15.42% | 10.89% | -28.28% | 5.31% | -10.51% | -0.19% | -28.77% | 12.16% | -0.70% | ||
| FCF Margin | -251.93% | 18.69% | 10.64% | 13.79% | -2.26% | 15.23% | -26.44% | -7.12% | 30.69% | 25.30% | -20.86% | 0.15% | 26.08% | -5.02% | -34.01% | -14.58% | 13.06% | ||||
| Efficiency | |||||||||||||||||||||
| Inventory AverageInventory Avg. | 1.06M | 4.33M | 3.81M | 3.99M | 4.98M | 6.12M | 6.13M | 5.56M | 6.20M | 7.50M | 8.02M | ||||||||||
| Assets AverageAssets Avg. | 249.54M | 517.45M | 795.49M | 1,008.68M | 1,054.00M | 1,047.07M | 1,018.76M | 1,055.20M | 1,092.44M | 1,084.88M | 1,069.68M | 1,095.76M | |||||||||
| Invested CapitalInvested Cap. | 121.48M | 281.43M | 401.16M | 373.29M | 395.90M | 416.85M | 797.08M | 797.26M | 816.52M | 751.73M | 770.01M | 780.54M | 789.15M | 774.16M | 787.33M | 814.00M | |||||
| Asset Utilization RatioAsset Util. | 0.30 | 0.33 | 0.28 | 0.28 | 0.30 | 0.33 | 0.34 | 0.35 | 0.37 | 0.39 | 0.39 | ||||||||||
| Leverage & Solvency | |||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -23.50 | -28.07 | -11.78 | 3.46 | -7.03 | -11.76 | -10.08 | -10.71 | -13.03 | -8.18 | -3.74 | -1.98 | -2.76 | -1.20 | -4.89 | -2.36 | -6.45 | 2.39 | -0.98 | ||
| Debt Ratio | 0.19 | 0.12 | 0.10 | 0.09 | 0.09 | 0.08 | 0.44 | 0.43 | 0.40 | 0.39 | 0.38 | 0.36 | 0.36 | 0.37 | 0.37 | 0.35 | |||||
| Times Interest Earned | -23.50 | -28.07 | -11.78 | 3.46 | -7.03 | -11.76 | -10.08 | -10.71 | -13.03 | -8.18 | -3.74 | -1.98 | -2.76 | -1.20 | -4.89 | -2.36 | -6.45 | 2.39 | -0.98 | ||
| Valuation | |||||||||||||||||||||
| Price to EarningsP/E | -28.36 | -28.29 | -83.13 | 280.51 | -92.84 | -122.94 | -166.59 | 0.00M | -172.19 | -132.78 | -145.75 | 178.26 | -62.13 | 298.75 | -153.46 | -0.01M | -58.53 | 118.15 | -0.00M | ||
| Price to SalesP/S | 144.27 | 168.99 | 40.61 | 42.40 | 48.68 | 43.76 | 49.11 | 40.25 | 48.42 | 46.10 | 22.48 | 19.41 | 17.57 | 15.86 | 16.14 | 17.68 | 16.84 | 14.37 | 14.10 | ||
| Price to BookP/B | 4.23 | 6.49 | 7.89 | 5.93 | 8.39 | 7.01 | 8.35 | 7.33 | 9.21 | 9.04 | 4.72 | 4.12 | 4.09 | 3.93 | 4.07 | 4.62 | 4.62 | 3.89 | 3.89 | ||
| Enterprise Value | 824.51M | 1,181.19M | 1,374.51M | 1,649.74M | 2,354.36M | 2,391.88M | 2,506.13M | 2,610.12M | 2,954.63M | 2,417.57M | 835.50M | 656.02M | 656.54M | 651.93M | 697.84M | 941.15M | 895.27M | 687.69M | 754.28M | ||
| EV to EBIT | -19.32 | -23.16 | -66.31 | 226.80 | -89.91 | -162.76 | -126.97 | -184.54 | -173.27 | -91.26 | -52.16 | -77.16 | -33.75 | -180.29 | -46.91 | -131.24 | -45.47 | 94.46 | -251.76 | ||
| EV to EBITDA | -19.32 | -23.16 | -66.31 | 226.80 | -89.91 | -162.76 | -126.97 | -184.54 | -173.27 | -91.26 | -52.16 | -77.16 | -33.75 | -180.29 | -46.91 | -131.24 | -45.47 | 94.46 | -251.76 | ||
| Market Capitalization | 1,178.19M | 1,501.86M | 1,636.52M | 2,058.92M | 2,744.40M | 2,391.88M | 2,934.52M | 2,610.12M | 3,397.26M | 3,250.40M | 1,695.10M | 1,557.30M | 1,476.91M | 1,488.98M | 1,580.68M | 1,833.50M | 1,759.42M | 1,532.58M | 1,634.50M | ||
| Price to FCFP/FCF | -67.08 | 226.88 | 457.53 | 317.31 | -0.00M | 264.26 | -183.14 | -647.88 | 73.25 | 76.72 | -84.23 | 0.01M | 61.87 | -352.33 | -49.51 | -98.52 | 107.94 | ||||
| EV to FCF | -52.75 | 181.79 | 392.50 | 317.31 | -0.00M | 264.26 | -159.28 | -481.88 | 36.10 | 32.32 | -37.44 | 0.00M | 27.31 | -180.85 | -25.19 | -44.21 | 49.81 | ||||
| EV to CFO | -53.65 | 172.94 | 332.77 | 226.95 | 0.06M | 258.71 | -166.62 | -527.05 | 35.60 | 31.05 | -47.06 | 0.00M | 26.88 | -211.21 | -27.42 | -49.92 | 47.36 | ||||
| Return Ratios | |||||||||||||||||||||
| Return on Sales [ROS]ROS | -522.45% | -573.82% | -51.43% | 14.98% | -46.45% | -26.89% | -33.03% | -21.81% | -24.30% | -37.57% | -21.24% | -10.59% | -23.14% | -3.85% | -15.18% | -6.92% | -18.85% | 6.82% | -2.58% | ||
| Return on Capital Employed [ROCE]ROCE | -21.58% | -12.09% | -8.95% | -8.64% | -8.44% | -5.47% | -5.25% | -4.89% | -5.41% | -4.15% | -2.62% | ||||||||||
| Return on Invested Capital [ROIC]ROIC | -23.07% | -11.69% | -8.59% | -7.39% | -8.68% | -5.95% | -5.46% | -5.98% | -10.81% | -10.22% | -18.68% | ||||||||||
| Return on Assets [ROA]ROA | -18.36% | -7.66% | -5.45% | -4.47% | -4.88% | -2.13% | -1.93% | -2.68% | -3.28% | -2.58% | -1.65% |